BioCentury | Sep 2, 2017
Strategy

Back to School 2017: Breach of contract

...The drug industry can’t absolve itself by disavowing the egregious actions of outliers such as Marathon Pharmaceuticals LLC...
...Tokyo, Japan Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Kaiser Family Foundation, Menlo Park. Calif. Marathon Pharmaceuticals LLC...
BioCentury | Jun 6, 2017
Clinical News

FDA panel to review PTC's Translarna for DMD

...the EU. PTC has another DMD therapy, the steroid Emflaza deflazacort, which it acquired from Marathon Pharmaceuticals LLC...
...PTC gained $0.76 to $14.31 on Tuesday, while Sarepta was off $0.06 to $31.50. Mary Romeo Emflaza Exondys 51 Translarna Marathon Pharmaceuticals LLC PTC...
BioCentury | Jun 2, 2017
Clinical News

ViiV submits Priority Review voucher with HIV combo

...other vouchers FDA has granted remain unused (see BioCentury, June 1, 2015) . In February, Marathon Pharmaceuticals LLC...
...guselkumab to treat psoriasis. Mary Romeo bictegravir Brineura Edurant Emflaza emtricitabine/tenofovir alafenamide Kanuma Sirturo Strensiq Tivicay Alexion Pharmaceuticals Inc. Biogen Inc. BioMarin Pharmaceutical Inc. Gilead Sciences Inc. GlaxoSmithKline plc Johnson & Johnson Marathon Pharmaceuticals LLC Pfizer...
BioCentury | May 12, 2017
Company News

PTC reveals price of steroid for DMD

...CureDuchenne told BioCentury an average DMD patient weighs about 40 kg. PTC acquired Emflaza from Marathon Pharmaceuticals LLC...
BioCentury | May 9, 2017
Politics & Policy

PhRMA revises eligibility criteria, cutting membership

...PhRMA also eliminated its category of associate members, which included 15 companies. Among them were Marathon Pharmaceuticals LLC...
...18) . Becky Simon AMAG Pharmaceuticals Inc. BioMarin Pharmaceutical Inc. Esperion Therapeutics Inc. Horizon Pharma plc Jazz Pharmaceuticals plc Leadiant Biosciences S.p.A. Mallinckrodt plc Marathon Pharmaceuticals LLC Pharmaceutical...
BioCentury | May 8, 2017
Company News

PTC reveals price of steroid for DMD

...BioCentury an average DMD patient weighs about 40 kg. PTC acquired Emflaza last month from Marathon Pharmaceuticals LLC...
...date. Translarna is a small molecule that facilitates complete translation of proteins containing nonsense mutations. Chris Lieu Emflaza Translarna Marathon Pharmaceuticals LLC PTC...
BioCentury | Apr 7, 2017
Finance

Fade to black

...approvals1Q setbacks Selected 1Q approvals. (A) PTC Therapeutics Inc. (NASDAQ:PTCT) is acquiring Emflaza deflazacort from Marathon Pharmaceuticals...
...treat carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy when SSA is inadequate Marathon Pharmaceuticals LLC...
BioCentury | Mar 17, 2017
Company News

Marathon, PTC deal

...inquiries. Marathon Pharmaceuticals LLC , Northbrook, Ill. PTC Therapeutics Inc. (NASDAQ:PTCT), South Plainfield, N.J. Business: Musculoskeletal Jaime De Leon ataluren deflazacort Emflaza MP-104 Translarna Marathon Pharmaceuticals LLC PTC...
BioCentury | Mar 16, 2017
Company News

Marathon offloads Emflaza to PTC

...criticism over the drug's proposed price, PTC Therapeutics Inc. (NASDAQ:PTCT) is acquiring Emflaza deflazacort from Marathon Pharmaceuticals LLC...
...Translarna is a small molecule that facilitates complete translation of proteins containing nonsense mutations. Jaime De Leon ataluren deflazacort Emflaza MP-104 Translarna Marathon Pharmaceuticals LLC PTC...
BioCentury | Mar 15, 2017
Politics & Policy

Sanders, Cummings press FDA on Marathon's Emflaza

...Rep. Elijah Cummings (D-Md.) asked the agency to defend its approval of Emflaza deflazacort from Marathon Pharmaceuticals LLC...
...it expects over its seven years of market exclusivity (see BioCentury Extra, March 6) . Becky Simon Emflaza Marathon Pharmaceuticals LLC...
Items per page:
1 - 10 of 32
BioCentury | Sep 2, 2017
Strategy

Back to School 2017: Breach of contract

...The drug industry can’t absolve itself by disavowing the egregious actions of outliers such as Marathon Pharmaceuticals LLC...
...Tokyo, Japan Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Kaiser Family Foundation, Menlo Park. Calif. Marathon Pharmaceuticals LLC...
BioCentury | Jun 6, 2017
Clinical News

FDA panel to review PTC's Translarna for DMD

...the EU. PTC has another DMD therapy, the steroid Emflaza deflazacort, which it acquired from Marathon Pharmaceuticals LLC...
...PTC gained $0.76 to $14.31 on Tuesday, while Sarepta was off $0.06 to $31.50. Mary Romeo Emflaza Exondys 51 Translarna Marathon Pharmaceuticals LLC PTC...
BioCentury | Jun 2, 2017
Clinical News

ViiV submits Priority Review voucher with HIV combo

...other vouchers FDA has granted remain unused (see BioCentury, June 1, 2015) . In February, Marathon Pharmaceuticals LLC...
...guselkumab to treat psoriasis. Mary Romeo bictegravir Brineura Edurant Emflaza emtricitabine/tenofovir alafenamide Kanuma Sirturo Strensiq Tivicay Alexion Pharmaceuticals Inc. Biogen Inc. BioMarin Pharmaceutical Inc. Gilead Sciences Inc. GlaxoSmithKline plc Johnson & Johnson Marathon Pharmaceuticals LLC Pfizer...
BioCentury | May 12, 2017
Company News

PTC reveals price of steroid for DMD

...CureDuchenne told BioCentury an average DMD patient weighs about 40 kg. PTC acquired Emflaza from Marathon Pharmaceuticals LLC...
BioCentury | May 9, 2017
Politics & Policy

PhRMA revises eligibility criteria, cutting membership

...PhRMA also eliminated its category of associate members, which included 15 companies. Among them were Marathon Pharmaceuticals LLC...
...18) . Becky Simon AMAG Pharmaceuticals Inc. BioMarin Pharmaceutical Inc. Esperion Therapeutics Inc. Horizon Pharma plc Jazz Pharmaceuticals plc Leadiant Biosciences S.p.A. Mallinckrodt plc Marathon Pharmaceuticals LLC Pharmaceutical...
BioCentury | May 8, 2017
Company News

PTC reveals price of steroid for DMD

...BioCentury an average DMD patient weighs about 40 kg. PTC acquired Emflaza last month from Marathon Pharmaceuticals LLC...
...date. Translarna is a small molecule that facilitates complete translation of proteins containing nonsense mutations. Chris Lieu Emflaza Translarna Marathon Pharmaceuticals LLC PTC...
BioCentury | Apr 7, 2017
Finance

Fade to black

...approvals1Q setbacks Selected 1Q approvals. (A) PTC Therapeutics Inc. (NASDAQ:PTCT) is acquiring Emflaza deflazacort from Marathon Pharmaceuticals...
...treat carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy when SSA is inadequate Marathon Pharmaceuticals LLC...
BioCentury | Mar 17, 2017
Company News

Marathon, PTC deal

...inquiries. Marathon Pharmaceuticals LLC , Northbrook, Ill. PTC Therapeutics Inc. (NASDAQ:PTCT), South Plainfield, N.J. Business: Musculoskeletal Jaime De Leon ataluren deflazacort Emflaza MP-104 Translarna Marathon Pharmaceuticals LLC PTC...
BioCentury | Mar 16, 2017
Company News

Marathon offloads Emflaza to PTC

...criticism over the drug's proposed price, PTC Therapeutics Inc. (NASDAQ:PTCT) is acquiring Emflaza deflazacort from Marathon Pharmaceuticals LLC...
...Translarna is a small molecule that facilitates complete translation of proteins containing nonsense mutations. Jaime De Leon ataluren deflazacort Emflaza MP-104 Translarna Marathon Pharmaceuticals LLC PTC...
BioCentury | Mar 15, 2017
Politics & Policy

Sanders, Cummings press FDA on Marathon's Emflaza

...Rep. Elijah Cummings (D-Md.) asked the agency to defend its approval of Emflaza deflazacort from Marathon Pharmaceuticals LLC...
...it expects over its seven years of market exclusivity (see BioCentury Extra, March 6) . Becky Simon Emflaza Marathon Pharmaceuticals LLC...
Items per page:
1 - 10 of 32